| Edition |
Second edition. |
| Description |
1 online resource |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Intro -- Halftitle -- Title -- Copyright -- Dedication -- Preface to the 2nd Edition -- Preface -- Acknowledgements -- Coda: Beginnings -- Glossary -- Abbreviations -- Chapter 1 Drug Misuse -- 1.1 Introduction -- 1.2 Drug Misuse in England and Wales -- 1.2.1 Household Surveys of Drug Misuse -- 1.2.2 Drug-associated Deaths -- 1.2.3 Seizures by Law Enforcement Agencies -- References -- Chapter 2 International Drugs Control -- 2.1 Introduction -- 2.2 United Nations Single Convention on Narcotic Drugs, 1961 -- 2.3 United Nations Convention on Psychotropic Substances, 1971 |
|
2.4 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 -- 2.5 The Role of the European Union -- 2.5.1 'Joint Action': The Period 1997 to 2005 -- 2.5.2 The EU Council Decision of 2005 -- 2.5.3 The Period since 2018 -- 2.6 Legislative Developments in Other Countries -- References -- Chapter 3 Primary UK Drugs Legislation up to 1971 -- 3.1 Drug Control in the UK before 1971 -- 3.2 The Misuse of Drugs Act 1971 -- 3.3 Offences and Penalties under the MDAct -- 3.3.1 Cultivation of Cannabis -- 3.3.2 Production of a Controlled Drug |
|
3.4 The Advisory Council on the Misuse of Drugs -- 3.5 Reviews of the MDAct -- 3.5.1 Review by the ACMD (1979) -- 3.5.2 The Independent Enquiry into the MDAct (2000) -- 3.5.3 Home Affairs Select Committee (2001-2) -- 3.5.4 Select Committee on Science and Technology (2006) -- 3.5.5 Royal Society of Arts Report (2007) -- 3.5.6 Demos Report 'Taking Drugs Seriously' (2011) -- 3.5.7 Home Affairs Select Committee (2012) -- 3.5.8 All-Party Parliamentary Group for Drug Policy Reform (2013) -- 3.5.9 Royal Society for Public Health (2016) -- 3.5.10 Royal Society of Arts (2017) |
|
3.5.11 House of Commons Health and Social Care Committee: Drugs Policy (2019) -- 3.5.12 Independent Review of Drugs by Dame Carol Black (2021) -- 3.5.13 Problem Drugs Bill: A Private Members' Bill Tabled by Tommy Sheppard MP (2021) -- 3.6 Substances Removed and/or Reinstated -- 3.7 Cannabis: Classification and Reclassification -- 3.8 The Classification of MDMA -- 3.9 The Precautionary Principle -- 3.10 Conclusions -- References -- Chapter 4 The Misuse of Drugs Regulations 2001 -- 4.1 Introduction -- 4.2 Regulations Relevant to Forensic Science |
|
4.2.1 Exceptions for Drugs in Schedules 4 and 5 and Poppy Straw -- 4.2.2 Exceptions for Drugs in Schedule 1 -- 4.2.3 Exceptions for Gamma-butyrolactone and 1,4-Butanediol -- 4.3 The Impact of the MD Regulations on Scientific Research -- References -- Chapter 5 UK Drugs Legislation since 1971 -- 5.1 Drugs Act 2005 -- 5.2 Temporary Class Drug Orders -- 5.3 Importation Controls -- 5.4 The Psychoactive Substances Act 2016 -- 5.4.1 Alkyl Nitrites -- 5.4.2 Nitrous Oxide -- 5.4.3 Reviews of the Psychoactive Substances Act -- 5.5 Other Drug-related Legislation in the UK -- 5.5.1 Road Traffic Act 1972 |
| Summary |
Updating and expanding the coverage of the first Edition, this book provides a chemical background to domestic and international controls on substances of misuse. |
| Subject |
Chemistry, Forensic.
|
|
Forensic pharmacology.
|
|
Drugs of abuse -- Classification.
|
|
Drugs of abuse -- Law and legislation -- Great Britain.
|
|
Chimie légale.
|
|
Pharmacologie légale.
|
|
Chemistry, Forensic
|
|
Drugs of abuse
|
|
Drugs of abuse -- Law and legislation
|
|
Forensic pharmacology
|
|
Great Britain https://id.oclc.org/worldcat/entity/E39PBJdmp7p3cx8hpmJ8HvmTpP
|
| Genre/Form |
Classification
|
| Other Form: |
Print version: 1839164506 9781839164507 (OCoLC)1302182265 |
| ISBN |
9781839166648 (electronic bk.) |
|
1839166649 (electronic bk.) |
|
1839164506 |
|
9781839164507 |
|
